(Q51080364)

29 March 2018

title

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. (English)

1 reference

29 March 2018

1 reference

1 reference

Fava M

1

1 reference

29 March 2018

Rosenbaum JF

2

1 reference

29 March 2018

Hoog SL

3

1 reference

29 March 2018

Tepner RG

4

1 reference

29 March 2018

Kopp JB

5

1 reference

29 March 2018

Nilsson ME

6

1 reference

29 March 2018

publication date

1 August 2000

1 reference

29 March 2018

Journal of Affective Disorders

published in

1 reference

29 March 2018

volume

59

1 reference

29 March 2018

issue

2

1 reference

29 March 2018

page(s)

119-126

1 reference

29 March 2018

Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900131-7

7 January 2021

Follow-up and family study of anxious depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900131-7

7 January 2021

A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900131-7

7 January 2021

A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo in Outpatients with Major Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900131-7

7 January 2021

Anxious depression in elderly patients. Response to antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900131-7

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900131-7

7 January 2021

Anxious and nonanxious depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900131-7

7 January 2021

A double-blind comparison of sertraline and clomipramine in the treatment of major depressive disorder and associated anxiety in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900131-7

7 January 2021

Tricyclic nonresponders: phenomenology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900131-7

7 January 2021

Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900131-7

7 January 2021

Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900131-7

7 January 2021

Anxious depressions. Clinical, family history, and naturalistic outcome--comparisons with panic and major depressive disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900131-7

7 January 2021

10.1016/S0165-0327(99)00131-7

Identifiers

DOI

1 reference

29 March 2018

1 reference

29 March 2018